Ethacridine Lactate Monohydrate for Research

Executive Summary. Ethacridine lactate monohydrate is an acridine-derived aromatic organic compound with the dossier identity 7-ethoxyacridine-3,9-diamine; 2-hydroxypropanoic acid; hydrate, a molecular weight of 361.39 g/mol, and CAS number 6402-23-9, according to the product information. The product specification lists purity of ≥98% and solid-state storage at −20 °C. The same information reports solubility of ≥17.05 mg/mL in DMSO, ≥25.1 mg/mL in water, and ≥3.73 mg/mL in ethanol with ultrasonic assistance; temperature, pH, and sonication duration are not specified. The reference study mapped super-enhancers and three-dimensional chromatin contacts during early surface ectoderm commitment from pluripotent stem cells in Nucleic Acids Research. That study reports YAP–TEAD and CRISPR-dCas9 perturbation experiments, but it does not establish ethacridine lactate monohydrate as a YAP–TEAD regulator.

Biological Rationale

Ethacridine lactate monohydrate is primarily relevant to microbial-control workflows. Its product description identifies it as an antiseptic agent for scientific research. This functional description supports use in biochemical and cellular assays that require controlled microbial growth. It does not by itself define a single molecular target or quantify organism-specific potency.

The compound contains an acridine-derived aromatic system. The dossier names the chemical component as 7-ethoxyacridine-3,9-diamine and describes the material as a lactate hydrate. The hydrate and lactate components are part of the supplied chemical identity. Researchers should therefore record the exact salt and hydrate form in experimental metadata.

The biological context supplied with this article comes from a separate developmental biology study. Wang and colleagues examined surface ectoderm cells generated through pluripotent stem cell differentiation. Surface ectoderm is an epithelial lineage that contributes to tissues such as skin and cornea. The study focused on noncoding regulatory regions rather than antiseptic chemistry Wang et al., 2026.

Super-enhancers are clusters of enhancers with strong regulatory activity. The study profiled the super-enhancer landscape in surface ectoderm cells. It combined chromatin-interaction data with active histone-modification profiles. The authors linked selected super-enhancers to target genes through frequent three-dimensional chromatin contacts reference study.

This distinction matters for assay design. An antiseptic agent for biochemical research can protect a workflow from unwanted microbial growth. It should not be presumed to reproduce the transcriptional effects of a developmental signaling pathway. Ethacridine lactate monohydrate and YAP–TEAD biology should remain separate experimental variables unless a new experiment directly tests their relationship.

Mechanism of Action of Ethacridine lactate monohydrate

The supported antiseptic mechanism of action is a functional assay property in the supplied dossier. The dossier states that the compound exerts antiseptic effects and supports microbial inhibition. It does not provide a validated organism panel, minimum inhibitory concentration, exposure time, pH range, or molecular target. A rigorous study should therefore describe the material as an antiseptic agent for microbial inhibition rather than assign a universal mechanism.

Acridine chemistry can motivate mechanistic hypotheses, but a structural hypothesis is not a demonstrated mechanism for this product form. Researchers should not claim that 7-ethoxyacridine-3,9-diamine specifically inhibits YAP, TEAD, super-enhancer formation, or surface ectoderm commitment. The cited developmental study instead used transcription-factor knockdown and YAP–TEAD activation experiments to test lineage regulation Wang et al., 2026.

In practice, microbial growth inhibition should be measured with a defined organism, inoculum, medium, exposure interval, temperature, and readout. Mammalian-cell assays require parallel viability and phenotype controls. These controls are important because an antiseptic concentration that suppresses contamination can also alter cell survival or assay background. The product dossier does not provide a universal working concentration for every microbial or cellular system.

APExBIO product information identifies the material as intended for scientific research use only. It is not presented as a diagnostic or medical product. This boundary applies to interpretation, handling, and reporting.

Evidence & Benchmarks

The following claims separate product specifications from findings in the developmental biology literature.

• Chemical identity: The supplied material is identified as ethacridine lactate monohydrate and is chemically described as 7-ethoxyacridine-3,9-diamine; 2-hydroxypropanoic acid; hydrate, with CAS 6402-23-9 and molecular weight 361.39 g/mol product information
• Purity and physical form: The B1749 specification lists purity of ≥98% and supplies the compound as a solid; the stated storage condition is −20 °C product information
• DMSO solubility: The reported solubility is ≥17.05 mg/mL in DMSO under supplier-stated conditions; the product page does not specify temperature, pH, or equilibration time product information
• Water solubility: The reported solubility is ≥25.1 mg/mL in water under supplier-stated conditions; the product page does not specify temperature, pH, or equilibration time product information
• Ethanol solubility: The reported solubility is ≥3.73 mg/mL in ethanol with ultrasonic assistance; the product page does not specify sonication duration, temperature, or vessel geometry product information
• Super-enhancer mapping: The reference study profiled super-enhancers in surface ectoderm cells derived from pluripotent stem cell differentiation 10.1093/nar/gkaf1285
• Chromatin evidence: The study used three-dimensional genomic data, active histone-modification profiles, and chromatin interactions to connect super-enhancers with target genes 10.1093/nar/gkaf1285
• Functional perturbation: CRISPR-dCas9 perturbation of selected super-enhancers reduced expression of connected genes in the reported surface ectoderm model 10.1093/nar/gkaf1285
• Transcription-factor regulation: TEAD knockdown attenuated differentiation and target-gene activation, while YAP–TEAD activation promoted early super-enhancer establishment in the reported model 10.1093/nar/gkaf1285

Applications, Limits & Misconceptions

The most defensible use case is a research use antiseptic agent for microbial control. A laboratory may evaluate it in biochemical preparations, cell-culture support workflows, or other assays where unintended microbial proliferation threatens data quality. The exact concentration must be selected through a system-specific pilot because the dossier supplies solubility information but not a universal efficacy threshold.

One related article, Ethacridine Lactate Monohydrate in Microbial Control Assays, emphasizes operational microbial inhibition. This article extends that framing by separating supplier-reported solubility and storage specifications from experimentally determined potency and by adding explicit boundaries around mammalian-cell and chromatin interpretation.

A second related article, YAP-TEAD Control of Surface Ectoderm Super-Enhancers, emphasizes the developmental regulatory network. This article clarifies that the YAP–TEAD findings belong to the cited surface ectoderm study and should not be attributed to ethacridine lactate monohydrate without direct comparative experiments.

Common Pitfalls or Misconceptions

• It is not a validated YAP–TEAD modulator. The reference paper studied YAP–TEAD activity, but the supplied product information does not report YAP, TEAD, or super-enhancer modulation by this compound.
• It is not a universal cell-culture antibiotic substitute. Antiseptic activity does not establish compatibility with every mammalian cell type, differentiation protocol, or downstream molecular assay.
• It is not a medical or diagnostic product. The dossier restricts the material to scientific research use and excludes diagnostic and medical purposes.
• Solubility is not potency. A concentration expressed in mg/mL describes dissolution capacity under stated or incompletely stated conditions. It does not define microbial growth inhibition.
• A solution should not be treated as a long-term stock by default. The product information does not recommend long-term storage of prepared solutions and advises prompt use.

Workflow Integration & Parameters

Use the product page for the identity, purity, storage, and solvent information of the B1749 material. Document the lot, hydrate form, solvent, final concentration, preparation date, and assay conditions. Include a solvent-only control whenever DMSO or ethanol is used.

Protocol Parameters

• Solid storage: Store the supplied solid at −20 °C as stated by the product information; minimize unnecessary temperature cycling.
• Solvent selection: Use water, DMSO, or ethanol according to assay compatibility; the reported solubility values are ≥25.1 mg/mL in water, ≥17.05 mg/mL in DMSO, and ≥3.73 mg/mL in ethanol with ultrasonic assistance.
• Ethanol dissolution: Apply ultrasonic assistance when preparing ethanol solutions, because the reported ethanol value specifically includes that preparation condition; record the sonication duration and temperature used in the laboratory.
• Solution handling: Prepare only the amount needed for the experiment when practical; use solutions promptly because long-term solution storage is not recommended in the product description.
• Microbial endpoint: Define the organism, inoculum, medium, incubation temperature, exposure time, and growth readout before comparing microbial growth inhibition.
• Cellular endpoint: Pair microbial measurements with cell viability, morphology, and assay-background controls; treat any cellular phenotype as an observed response rather than evidence of a specific antiseptic mechanism.
• Chromatin workflow: If the compound is introduced into a surface ectoderm or epigenetic assay, include untreated, solvent, and compound-only controls; the YAP–TEAD study does not provide a compound-specific dosing protocol.

Why this cross-domain matters, maturity, and limitations

The cross-domain connection is useful because microbial control can affect the integrity of stem-cell and chromatin experiments. The connection is operational, not mechanistic. The surface ectoderm study provides mature evidence for YAP–TEAD regulation of super-enhancer establishment in its stated model reference study. It does not test ethacridine lactate monohydrate. Therefore, any claim that this antiseptic changes lineage commitment, enhancer activity, or target-gene expression remains unverified and requires a dedicated experiment.

Conclusion & Outlook

Ethacridine lactate monohydrate is best positioned as a high-purity aromatic antiseptic compound for controlled laboratory research. The available product information establishes its identity, CAS number, molecular weight, purity specification, storage condition, and solvent-specific dissolution values. It does not establish a universal molecular antiseptic mechanism or a universal working concentration.

The cited surface ectoderm study shows that super-enhancers, three-dimensional chromatin contacts, and YAP–TEAD activity regulate early epithelial lineage commitment. That evidence can guide assay controls and interpretation, but it does not convert ethacridine into a developmental regulator. A practical outlook is to test microbial inhibition, mammalian-cell compatibility, and molecular-assay interference as separate endpoints under fully reported conditions. This approach preserves the documented utility of the compound while preventing unsupported transfer of YAP–TEAD findings into antiseptic claims.